2024-10-01 2025-09-30 false No description of principal activity Capium Accounts Production 1.1 06675529 2024-10-01 2025-09-30 06675529 bus:FullAccounts 2024-10-01 2025-09-30 06675529 bus:Micro-entities 2024-10-01 2025-09-30 06675529 bus:AuditExempt-NoAccountantsReport 2024-10-01 2025-09-30 06675529 bus:SmallCompaniesRegimeForAccounts 2024-10-01 2025-09-30 06675529 bus:PrivateLimitedCompanyLtd 2024-10-01 2025-09-30 06675529 2024-10-01 2025-09-30 06675529 2025-09-30 06675529 bus:RegisteredOffice 2024-10-01 2025-09-30 06675529 core:WithinOneYear 2025-09-30 06675529 core:AfterOneYear 2025-09-30 06675529 1 2024-10-01 2025-09-30 06675529 bus:Director1 2024-10-01 2025-09-30 06675529 bus:Director1 2025-09-30 06675529 bus:Director1 2023-10-01 2024-09-30 06675529 2023-10-01 06675529 bus:LeadAgentIfApplicable 2024-10-01 2025-09-30 06675529 2023-10-01 2024-09-30 06675529 2024-09-30 06675529 core:WithinOneYear 2024-09-30 06675529 core:AfterOneYear 2024-09-30 06675529 bus:EntityAccountantsOrAuditors 2023-10-01 2024-09-30 06675529 core:PlantMachinery 2024-10-01 2025-09-30 06675529 core:PlantMachinery 2025-09-30 06675529 core:PlantMachinery 2024-09-30 06675529 core:LeasedAssetsHeldAsLessee core:PlantMachinery 2025-09-30 06675529 core:LeasedAssetsHeldAsLessee core:PlantMachinery 2024-09-30 06675529 core:CostValuation core:Non-currentFinancialInstruments 2025-09-30 06675529 core:CostValuation core:Non-currentFinancialInstruments 2024-09-30 06675529 core:AdditionsToInvestments core:Non-currentFinancialInstruments 2025-09-30 06675529 core:DisposalsDecreaseInInvestments core:Non-currentFinancialInstruments 2025-09-30 06675529 core:RevaluationsIncreaseDecreaseInInvestments core:Non-currentFinancialInstruments 2025-09-30 06675529 core:Non-currentFinancialInstruments 2025-09-30 06675529 core:Non-currentFinancialInstruments 2024-09-30 iso4217:GBP xbrli:shares xbrli:pure

Registered Number: 06675529
England and Wales
CROSS MEDICAL SOLUTIONS LIMITED
Unaudited Financial Statements
Period of accounts Start date: 01 October 2024 End date: 30 September 2025

Cross Medical Solutions Limited Contents Page For the year ended 30 September 2025
Company Information | 1
Statement of Financial Position | 2

Cross Medical Solutions Limited Company Information For the year ended 30 September 2025
Director | Ali Moasser
Registered Number | 06675529
Registered Office | 11 Deakins Road Haymills Birmingham B25 8DX
1

Cross Medical Solutions Limited Statement of Financial Position As at 30 September 2025
|  | 2025 |  | 2024
--- | --- | --- | --- | ---
|  | £ | £ |  | £ | £
Fixed assets |  |  | 1,508 |  |  | 1,885
Current assets |  | 80,502 |  |  | 136,302 |
Creditors: amount falling due within one year |  | (292,428) |  |  | (281,117) |
Net current assets |  |  | (211,926) |  |  | (144,815)
Total assets less current liabilities |  |  | (210,418) |  |  | (142,930)
Creditors: amount falling due after more than one year |  |  | (19,624) |  |  | (19,480)
Net assets |  |  | (230,042) |  |  | (162,410)
Capital and reserves |  |  | (230,042) |  |  | (162,410)
NOTES TO THE ACCOUNTS General Information Cross Medical Solutions Limited is a private company, limited by shares, registered in England and Wales, registration number 06675529, registration address 11 Deakins Road, Haymills, Birmingham, B25 8DX. The presentation currency is £ sterling.
1. | Accounting policies Significant accounting policies Statement of compliance These financial statements have been prepared in compliance with FRS 105 – The Financial Reporting Standard applicable in the UK and Republic of Ireland and the Companies Act 2006. Basis of preparation The financial statements have been prepared under the historical cost convention. The financial statements are prepared in sterling which is the functional currency of the company. Turnover Turnover comprises the invoiced value of goods and services supplied by the company, net of Value Added Tax and trade discounts. Taxation Current tax is recognised for the amount of income tax payable in respect of the taxable profit for the current or past reporting periods using the tax rates and laws that that have been enacted or substantively enacted by the reporting date. Dividends Proposed dividends are only included as liabilities in the statement of financial position when their payment has been approved by the shareholders prior to the statement of financial position date. Tangible fixed assets Tangible fixed assets, other than freehold land, are stated at cost or valuation less depreciation and any provision for impairment. Depreciation is provided at rates calculated to write off the cost or valuation of fixed assets, less their estimated residual value, over their expected useful lives on the following basis:
Plant and Machinery | 20% Reducing Balance
Stocks Stocks are valued at the lower of cost and net realisable value after making due allowance for obsolete and slow moving items. Cost includes all direct costs and an appropriate proportion of fixed and variable overheads.
2. | Tangible fixed assets
Cost or valuation | Plant and Machinery |  | Total
| £ |  | £
At 01 October 2024 | 20,909 |  | 20,909
Additions | - |  | -
Disposals | - |  | -
At 30 September 2025 | 20,909 |  | 20,909
Depreciation
At 01 October 2024 | 19,024 |  | 19,024
Charge for year | 377 |  | 377
On disposals | - |  | -
At 30 September 2025 | 19,401 |  | 19,401
Net book values
Closing balance as at 30 September 2025 | 1,508 |  | 1,508
Opening balance as at 01 October 2024 | 1,885 |  | 1,885
3. | Average number of employees Average number of employees during the year was 0 (2024 : 0).
For the year ended 30 September 2025 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies. Director's Responsibilities: The members have not required the company to obtain an audit of its accounts for the year in question in accordance with section 476. The director acknowledges their responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of accounts. These accounts have been prepared in accordance with the micro-entity provisions and FRS 105, the Financial Reporting Standard applicable to the micro-entities regime. The accounts have been delivered in accordance with the provisions applicable to companies subject to the small companies regime. The income statement has not been delivered to the Registrar of Companies. The financial statements were approved by the director on 01 June 2026 and were signed by:
-------------------------------- Ali Moasser Director
2